Aclaris Therapeutics, Inc. is a specialty pharmaceutical company focused on the development of a topically applied therapy directed toward the removal of seborrheic keratosis (SK) and other verrucoid lesions of the skin.

from http://www.aclaristx.com/

Patents show all

3Issued1Applications

Clinical Trials show all

9Phase 23Phase 31Phase 1/Phase 2

SEC Filings show all

8-K2710-Q7D510-K2S-11

Overview

Total FundingEmployeesLast Funding DateStatus
$102,000,017101-2502016-06-14Ipo

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2014-10-02$21,000,000VentureSofinnova Ventures, F-Prime Capital Partners, Vivo Capital
2015-09-09$40,000,000VentureRA Capital ManagementAperture Venture Partners, Mossrock Capital, Cormorant Asset Management, Sofinnova Ventures, Vivo Capital, Rock Springs Capital, F-Prime Capital Partners
2012-10-24$21,000,000VentureVivo Capital, F-Prime Capital PartnersSofinnova Ventures
2016-06-14$20,000,017Post_ipo_equityAisling Capital